Literature DB >> 9380410

Gene structure of the human MET proto-oncogene.

F M Duh1, S W Scherer, L C Tsui, M I Lerman, B Zbar, L Schmidt.   

Abstract

By direct sequencing of cosmids using primers designed from the known cDNA sequence, we identified 19 exons in the human MET proto-oncogene, and sequenced the corresponding 5' and 3' exon-intron junctions. By homology search in the database of the Washington University Genome Sequence Center (GSC), we identified one additional exon. These 20 exons, together with a previously reported exon, bring the total exon number of MET to 21. Oligonucleotide primers were designed to amplify each exon and adjacent intronic sequences to permit examination of each exon for mutations. By restriction mapping, we assembled a 110 kb genomic contig that covered almost the entire MET proto-oncogene. This information is relevant for the screening of recently reported mutations of the MET gene which cause hereditary papillary renal carcinomas and for the search for additional mutations of the same gene which may play a role in the pathogenesis of common human carcinomas including carcinomas of the breast, ovary and pancreas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9380410     DOI: 10.1038/sj.onc.1201338

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  MET targeted therapy for lung cancer: clinical development and future directions.

Authors:  Yan Feng; Patrick C Ma
Journal:  Lung Cancer (Auckl)       Date:  2012-08-09

2.  Special issue: "MET as actionable target in cancer therapy".

Authors:  Patrick C Ma
Journal:  Ann Transl Med       Date:  2017-01

3.  Expression of the c-Met Proteins in Malignant Skin Cancers.

Authors:  Yoon-Jin Lee; Dae-Hyun Kim; Sang-Han Lee; Dong-Wook Kim; Hae-Seon Nam; Moon Kyun Cho
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

4.  Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis.

Authors:  K Fazekas; O Csuka; I Köves; E Rásó; J Tímár
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.

Authors:  I A Lubensky; L Schmidt; Z Zhuang; G Weirich; S Pack; N Zambrano; M M Walther; P Choyke; W M Linehan; B Zbar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

6.  Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.

Authors:  Qiu-Yuan Xia; Qiu Rao; Qin Shen; Shan-Shan Shi; Li Li; Biao Liu; Jin Zhang; Yan-Fen Wang; Qun-Li Shi; Jian-Dong Wang; Heng-Hui Ma; Zhen-Feng Lu; Bo Yu; Ru-Song Zhang; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 7.  The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care.

Authors:  Marina De Rosa; Daniela Rega; Valeria Costabile; Francesca Duraturo; Antonello Niglio; Paola Izzo; Ugo Pace; Paolo Delrio
Journal:  Therap Adv Gastroenterol       Date:  2016-08-07       Impact factor: 4.409

Review 8.  Origin of renal cell carcinomas.

Authors:  Manuel Valladares Ayerbes; Guadalupe Aparicio Gallego; Silvia Díaz Prado; Paula Jiménez Fonseca; Rosario García Campelo; Luis Miguel Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405

9.  Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.

Authors:  Melinda E Sanders; Rosemarie Mick; John E Tomaszewski; Frederic G Barr
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

10.  The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Authors:  Julia G Garcia; Maria M Picken; Robert C Flanigan
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.